SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 31.69-4.6%Nov 20 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (5366)1/22/1998 4:04:00 PM
From: Cacaito  Read Replies (1) of 17367
 
Protein C, is part of the fibrinolytic systems to balance clot formation
in the blood. There are diseases of protein C deficiency and the sufferers
are prone to form thrombi anywhere in the body (decrease ability to
decrease fibrin formation). Treatment: Plasma transfusion, and when
the patient is stable then Coumadin (warfarin). It is of hepatic origin,
and transient deficiencies can occur with liver diseases. It is also altered
during septic shock, but more complex issue. (caveat: this is from memory).

It tends to increase during infections,there were many attempts
to use it as a diagnostic marker of infections'but failed to become a
significant test due to poor ability to screen for infections,
not better than a regular white cell count, neither better when used
in combination with white cells count.

Hepatectomy trials and BPI, I do not know their destiny.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News